You are here

Renal Safety in the Elderly Task Force

As elderly cancer patients commonly show renal function decline, the taskforce was formed to discuss optimal clinical practices for treating patients of this group with renal insufficiency, paying particular attention to how renal function should be best monitored.

The taskforce outlined recommended dosing adjustments of anticancer drugs for elderly cancer patients according to their renal function.

Task Force Members

Chair: Vincent Launay-Vacher, France
Matti Aapro, Switzerland
Etienne Chatelut, France
Stuart Lichtman, USA
Christopher Steer, Australia
Hans Wildiers, Belgium


Renal insufficiency in elderly cancer patients:
International Society of Geriatric Oncology clinical practice recommendations. Launay-Vacher V, et al. Ann Oncol 2007; 18:1314-31
International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Lichtman SM, et al. Eur J Cancer 2007; 43: 14-34

This project was supported by an unrestricted grant from Roche.